Shahin Gharakhanian, MD, DPH Program Lead & Chair, Coordinator of the Summit Expert Advisory Group, Cambridge MA, USA.
Laure Berliner, Pharm D, MBA Chair, French American Biotech Spring Board (FABS) & Board Member, French American Chamber of Commerce of New England (FACCNE). Cambridge MA, USA.
Pravin Chaturvedi, PhD Scientific Advisory Board, NAPO Pharmaceuticals, Woburn MA.
Bernard Davidian, PhD  Vice President and Managing Director, Sanofi-Genzyme BioVentures, Cambridge MA, USA.
Denis Gauvreau, PhD  Director of International Affairs, Génopole, Evry, FR.
Camilla Graham, MD, MPH, Assistant Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School. Vice President, Medical & Government Affairs, TREK Therapeutics, Cambridge MA, USA.
Maryvonne Hiance, Dipl Eng.  President, France-Biotech: French Association of Biotechnology, Paris, FR.
Sofia Ioannidou, PhD Director BioDiscovery, ANDERA Partners, Paris, FR. Fmr. Investment Director, Life Sciences. Edmond de Rothschild Investment Partners SAS, Paris, FR.
Nicola La Monica,

PhD  

Senior Director, Infectious Disease Scientific Innovation @ Janssen, Pharmaceutical Companies of Johnson & Johnson, Boston MA, USA.
Pierre Legrain, PhD Vice-President for Development, Institut Pasteur, Paris, FR.
Sam Murphy, PhD VP and Head of International Business Development, Shenzhen Salubris Pharmaceuticals Co Ltd. Salubris Biotherapeutics Inc.
Michel Nowak Managing Partner, Nowak Ventures LLC, Boston MA, USA.
Jonathan FX O’Brian, JD Murphy & King PC, Counsellors at Law, Boston, MA, USA.
Stephan Ogenstad, PhD President, Statogen Consulting LLC. President & Secretary, North Carolina Chapter, American Statistical Association 2007-2017. Program Chair, Statistical Consulting Section, American Statistical Association 2009. Adjunct Faculty Member and Professor of Biostatistics, College of Public Health, Georgia Southern University.
Christine Sarkisian International Business Development, Co-Founder of Canadian Technology Accelerator, Consulate General of Canada, Boston MA.
Priya Singhal, MD SVP & Global Head, Safety and Benefit-Risk Management — Biogen, Inc., Cambridge MA.
Jacques-Bernard Taste President & Founder, Biotech-Finances, Lyon, France / Montréal, Québec, Canada.
Patrick Tricoli, PharmD, MBA CEO Nanobiotix USA & VP Corporate Dev. Nanobiotix SA, Boston MA.
Gail Triggs Fmr. Vice -President, Medical Affairs Dept. Vertex Pharmaceuticals, Boston, MA.